跳至主要内容
临床试验/CTRI/2025/04/085242
CTRI/2025/04/085242尚未招募不适用

TO STUDY THE ROLE OF INDIVIDUALIZED HOMOEOPATHIC MANAGEMENT IN CASES OF GOUT – A PROSPECTIVE INTERVENTIONAL STUDY

YASH PATIDAR1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2025年3月6日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
55
试验地点
1
主要终点
1.To evaluate the role of individualized homoeopathic medicine in Gout

研究概览

简要总结

The study is prospective interventional study the role of Individualized Homoeopathic Management in cases of Gout. The study will be conducted in 55 participants which will be enrolled in Jawaharlal Nehru Homoeopathic Medical College Hospital, Vadodara, Gujarat, India. GAQ2 will be used for assessment purpose. The study will be conducted in the time duration of 1 year.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 78.00 Year(s)(—)
性别
All

入选标准

  • 1.Patient between the ages of 18 to
  • 2.Patients suffering from chronic gout with high UA levels (27 mg/dL) 3.The gout had to be clinically apparent, with symptoms such as joint pains 4.The patients giving their consent to participate in study.

排除标准

  • 1.Pregnant and lactating women.
  • 2.Patient with septic arthritis, trauma, renal failure.
  • 3.Patients already undergoing treatment with other system of medicine.
  • 4.Cases with less than 6 follow up.

结局指标

主要结局

1.To evaluate the role of individualized homoeopathic medicine in Gout

时间窗: 3 MONTHS

levels in gout patients.

时间窗: 3 MONTHS

2.To investigate the role of individualized homoeopathic medicine in reducing serum uric acid

时间窗: 3 MONTHS

3.To improve the quality of life of the patients.

时间窗: 3 MONTHS

次要结局

  • GOUT ASSESSMENT QUESTIONNARE 2.O IS USED FOR ASSESSMENT FOR GOUT.(HIGHER SCORE = WORSE CONDITION / GREATER GOUT IMPACT)

研究者

发起方
YASH PATIDAR
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验